SCHEMBL746534

SCHEMBL746534

O=S(=O)(c1ccccc1Cl)N1CCC2(CCN(c3ccc(C4CC4)cc3)C2)CC1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 7/20 0.48
CYP1A2 P05177 7/20 0.48
CYP2C9 P11712 6/20 0.48
ALDH1A1 P00352 5/20 0.48
CYP2C19 P33261 5/20 0.48
TSHR P16473 4/20 0.48
CYP2D6 P10635 3/20 0.48
USP2 O75604 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
CCR1 P32246 7/20 0.44
HSD17B10 Q99714 1/20 0.44
FAAH O00519 2/20 0.42
LIPE Q05469 1/20 0.42
HIF1A Q16665 2/20 0.42
MAPK1 P28482 1/20 0.42
CHRM4 P08173 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL745542 0.83 CYP2C9 (0.52) CYP3A4CYP1A2CYP2C9ALDH1A1CYP2C19
SCHEMBL744705 0.82 CYP1A2 (0.47) CYP3A4CYP1A2CYP2C9ALDH1A1CYP2C19
SCHEMBL746711 0.82 CYP2C9 (0.48) CYP3A4CYP1A2CYP2C9ALDH1A1CYP2C19
SCHEMBL3740078 0.80 LIPE (0.66) CCR1LIPE
SCHEMBL744430 0.79 LIPE (0.68) CYP3A4CYP1A2CYP2C9ALDH1A1CYP2C19
SCHEMBL744989 0.77 CYP3A4 (0.57) CYP3A4CYP1A2CYP2C9ALDH1A1CYP2C19
SCHEMBL746622 0.76 CCR1 (0.44) CYP3A4CYP1A2CYP2C9ALDH1A1CYP2C19
SCHEMBL2955821 0.75 MMP2 (0.61) ALDH1A1TSHRSMN1; SMN2CCR1FAAH
SCHEMBL744218 0.73 CYP3A4 (0.52) CYP3A4CYP1A2CYP2C9ALDH1A1CYP2C19
SCHEMBL2953603 0.72 MAPT (0.59) ALDH1A1TSHRFAAHCHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430023-A1 AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS F. Hoffmann-La Roche AG (CH) 2012-03-21 EP claimed
WO-2010130665-A1 AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2010-11-18 WO claimed